
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (03): 280-285.DOI: 10.12114/j.issn.1007-9572.2023.0306
Special Issue: 中医最新文章合辑; 心血管最新文章合辑; 女性健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2023-06-01
Revised:2023-08-02
Published:2024-01-20
Online:2023-10-23
Contact:
BAI Wenpei
通讯作者:
白文佩
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0306
| 体检项目 | 基线 | 3年后 | t配对值 | P值 |
|---|---|---|---|---|
| 腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
| BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
| UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
| TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
| TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
| FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
| HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
| LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
Table 1 Follow-up results of research subjects
| 体检项目 | 基线 | 3年后 | t配对值 | P值 |
|---|---|---|---|---|
| 腰围(cm) | 76.31±7.25 | 77.91±7.62 | -5.120 | <0.001 |
| BMI(kg/m2) | 23.2±3.0 | 23.3±3.2 | -0.297 | 0.767 |
| UA(μmol/L) | 261.71±48.84 | 279.91±58.11 | -8.916 | <0.001 |
| TC(mmol/L) | 4.76±0.59 | 5.01±0.76 | -7.885 | <0.001 |
| TG(mmol/L) | 1.02±0.38 | 1.22±0.71 | -6.054 | <0.001 |
| FBG(mmol/L) | 5.24±0.56 | 5.16±0.65 | 3.820 | <0.001 |
| HDL-C(mmol/L) | 1.49±0.28 | 1.46±0.30 | 0.306 | 0.760 |
| LDL-C(mmol/L) | 2.78±0.58 | 2.87±0.68 | -2.072 | 0.039 |
| 组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
| 绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
| t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
| P值 | 0.235 | 0.566 | 0.358 | 0.683 | |||||
Table 2 Comparison of waist circumference and BMI between the two groups
| 组别 | 人数 | 腰围(cm) | BMI(kg/m2) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 75.76±6.78 | 77.62±7.47 | -3.806 | <0.001 | 23.0±2.8 | 23.2±3.1 | -0.755 | 0.451 |
| 绝经组 | 291 | 76.66±7.53 | 78.09±7.72 | -3.682 | <0.001 | 23.3±3.2 | 23.3±3.2 | 0.357 | 0.722 |
| t值 | 1.189 | 0.574 | 0.921 | 0.409 | |||||
| P值 | 0.235 | 0.566 | 0.358 | 0.683 | |||||
| 组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
| 绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
| t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
| P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
| 组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
| 绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
| t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
| P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 | |||||||
Table 3 Comparison of laboratory examination indexes between the two groups
| 组别 | 人数 | UA(μmol/L) | TC(mmol/L) | TG(mmol/L) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 176 | 260.09±50.07 | 268.69±58.34 | -2.897 | 0.004 | 4.74±0.58 | 4.85±0.66 | -2.932 | 0.004 | 1.02±0.39 | 1.19±0.55 | -4.836 | <0.001 |
| 绝经组 | 291 | 262.69±48.13 | 286.69±57.00 | -8.935 | <0.001 | 4.77±0.60 | 5.10±0.79 | -7.543 | <0.001 | 1.02±0.38 | 1.25±0.79 | -4.577 | <0.001 |
| t值 | 0.556 | 3.278 | 0.573 | 3.521 | 0.005 | 0.804 | |||||||
| P值 | 0.578 | 0.001 | 0.567 | <0.001 | 0.996 | 0.422 | |||||||
| 组别 | FBG(mmol/L) | HDL-C(mmol/L) | LDL-C(mmol/L) | ||||||||||
| 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | 基线 | 3年后 | t配对值 | P值 | ||
| 未绝经组 | 5.20±0.57 | 5.15±0.65 | 1.213 | 0.227 | 1.47±0.31 | 1.45±0.32 | 0.173 | 0.863 | 2.77±0.58 | 2.76±0.58 | 0.435 | 0.664 | |
| 绝经组 | 5.26±0.55 | 5.17±0.66 | 1.803 | 0.072 | 1.50±0.27 | 1.47±0.29 | 0.259 | 0.796 | 2.80±0.58 | 2.95±0.73 | -2.881 | 0.005 | |
| t值 | 1.132 | 0.283 | 0.787 | 0.740 | 0.423 | 2.823 | |||||||
| P值 | 0.258 | 0.777 | 0.432 | 0.460 | 0.672 | 0.005 | |||||||
| 组别 | 人数 | CIMT增厚 | 高血压 |
|---|---|---|---|
| 未绝经组 | 176 | 11(6.3) | 9(5.1) |
| 绝经组 | 291 | 20(6.9) | 32(11.0) |
| χ2值 | 0.069 | 4.739 | |
| P值 | 0.793 | 0.029 |
Table 4 Comparison of the incidence of increased CIMT and hypertension between the two groups
| 组别 | 人数 | CIMT增厚 | 高血压 |
|---|---|---|---|
| 未绝经组 | 176 | 11(6.3) | 9(5.1) |
| 绝经组 | 291 | 20(6.9) | 32(11.0) |
| χ2值 | 0.069 | 4.739 | |
| P值 | 0.793 | 0.029 |
| 自变量 | CIMT增厚 | 高血压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
| 绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
| 年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
Table 5 Multivariate Logistic regression analysis of the effect of menopause and age on the incidence of increased CIMT and hypertension in middle-aged women
| 自变量 | CIMT增厚 | 高血压 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| β | SE | Wald χ2值 | P值 | OR(95%CI) | β | SE | Wald χ2值 | P值 | OR(95%CI) | |
| 绝经 | 0.258 | 0.441 | 0.343 | 0.558 | 1.295(0.545~3.075) | 0.271 | 0.360 | 0.564 | 0.452 | 1.311(0.647~2.654) |
| 年龄≥50岁 | 0.906 | 0.438 | 4.285 | 0.038 | 2.475(1.049~5.838) | 0.525 | 0.350 | 2.257 | 0.133 | 1.691(0.852~3.355) |
| [1] |
|
| [2] |
中华医学会妇产科学分会绝经学组. 中国绝经管理与绝经激素治疗指南2023版[J]. 中华妇产科杂志,2023,58(1):4-21. DOI:10.3760/cma.j.cn112141-20221118-00706.
|
| [3] |
|
| [4] |
中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等. 稳定性冠心病诊断与治疗指南[J]. 中华心血管病杂志,2018,46(9):680-694. DOI:10.3760/cma.j.issn.0253-3758.2018.09.004.
|
| [5] |
陈中国,朱晓丽,万宇婷,等. 颈动脉内膜中层厚度与冠心病的相关性分析[J]. 中华介入放射学电子杂志,2019,7(1):31-34. DOI:10.3877/cma.j.issn.2095-5782.2019.01.006.
|
| [6] |
罗兰,牛敏,高政南. 中心性肥胖及血糖异常与颈动脉内膜-中层厚度的相关性[J]. 中华糖尿病杂志,2019,11(3):196-200. DOI:10.3760/cma.j.issn.1674-5809.2019.03.007.
|
| [7] |
陈波,杨万勇,石新年,等. Hcy、Cyst C、RPB4和颈动脉内膜中层厚度检测在健康体检中预防作用的研讨[J]. 国际医药卫生导报,2020,26(3):314-317. DOI:10.3760/cma.j.issn.1007-1245.2020.03.006.
|
| [8] |
国家卫生健康委员会疾病预防控制局,国家心血管病中心,中国医学科学院阜外医院,等. 中国高血压健康管理规范(2019)[J]. 中华心血管病杂志,2020,48(1):10-46. DOI:10.3760/cma.j.issn.0253-3758.2020.01.004.
|
| [9] | |
| [10] |
中华医学会妇产科学分会绝经学组. 围绝经期异常子宫出血诊断和治疗专家共识[J]. 协和医学杂志,2018,9(4):313-319. DOI:10.3969/j.issn.1674-9081.2018.04.006.
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
张莹,杜鑫,李劼,等. 血清超敏C反应蛋白水平与颈动脉内膜中层厚度的相关性分析[J]. 中国综合临床,2021,37(1):26-30. DOI:10.3760/cma.j.cn101721-20200712-00010.
|
| [1] | ZHAO Qiyu, LI Xinyue, WU Minmin, CHEN Qiuxin. Regulatory Mechanisms and Targeted Therapeutic Research of Mitochondria in Ferroptosis Following Cerebral Hemorrhage [J]. Chinese General Practice, 2026, 29(32): 4827-4832. |
| [2] | TANG Haoqing, LI Mingyue, LONG Ren, ZHU Yinbo, LIANG Weihuan, ZHU Ping, ZHAO Wei, ZHAO Yang, LIU Xiaoyun. Management Burden of Diabetic Mellitus Patients with Multimorbidity among Middle Aged and Older Adults: a Cross-sectional Survey in 6 Community Medical Institutes of China [J]. Chinese General Practice, 2026, 29(32): 4786-4797. |
| [3] | WEI Xuejuan, WANG Lihua, WANG Li, REN Jinglin, YAN Haiqing, YU Haiyang, LIU Jingfeng. Effectiveness of an Intelligent Voice Outbound Call System as an Adjunct to Usual Care for Health Management in Older Community-dwelling Patients with "Three Highs" Multimorbidity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(31): 4635-4640. |
| [4] | XIAO Zhili, LU Chenxia, ZHU Hui, ZHANG Jia, CHEN Zhuangzhuang, SUN Wei, LIU Xiangchuxuan, LUO Cheng, XIAO Mingzhong, LI Xiaodong. Application and Future Prospects of CGM Technology in Co-management of MAFLD and T2DM [J]. Chinese General Practice, 2026, 29(31): 4521-4527. |
| [5] | KUANG Li, DING Xinxin, MA Yuanzhu. Application of Motivational Interviewing in Healthcare Provider-Patient Communication for Chronic Disease Management in Primary Care: from Principles to Practice [J]. Chinese General Practice, 2026, 29(31): 4536-4542. |
| [6] | WANG Shiyi, FAN Xiaojing, SI Yafei, ZHOU Zhongliang. Advances in Key Measurement Techniques for the Intrinsic Capacity of Elderly in the Context of Healthy Aging [J]. Chinese General Practice, 2026, 29(31): 4662-4666. |
| [7] | WANG Zhongkai, WU Changyong, LI Menghan, LUO Yihua, ZHANG Bingqing, PENG Yunzhu. Association between Remnant Cholesterol Inflammatory Index and Risk of Cardiometabolic Multimorbidity in Middle-aged and Older Adults [J]. Chinese General Practice, 2026, 29(31): 4573-4581. |
| [8] | LI Bin, GE Mengfei, HAN Jing, XIAO Yu, ZHONG Yu. The Influencing Factors of Physical and Mental Health of the Elderly at Home in the Community and the Empowerment Strategies of Medical Social Workers [J]. Chinese General Practice, 2026, 29(31): 4627-4634. |
| [9] | HAN Leyang, ZHENG Huixian, TIAN Yiran, TANG Haoqing, LONG Ren, LI Daihan, LIU Xiaoyun. Measuring Integrated Services for Rural Chronic Disease Patients Based on Formative Measurement Theory [J]. Chinese General Practice, 2026, 29(31): 4543-4550. |
| [10] | TIAN Xiangyang, ZHOU Yingsheng, GAO Ying. Prospects of Behavioral and Lifestyle Interventions for Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(31): 4513-4520. |
| [11] | HE Yang, YANG Rong, SHEN Can, YI Shanye, LIU Lidi, ZHAO Qian, WAN Zhi, LIAO Xiaoyang. Progress in Research on the Trajectory of Frailty and Its Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4372-4378. |
| [12] | GUO Zhihong, CHEN Yingying, LIU Dewu. Efficacy and Safety of Antibiotic Bone Cement Combined with Vacuum Sealing Drainage for Diabetic Foot: a Meta-analysis [J]. Chinese General Practice, 2026, 29(30): 4503-4512. |
| [13] | SUN Xiuqin, FENG Zhenlong, WEI Lanxuan, ZENG Yuxin, LIU Jinbo, MA Lin, AN Zhantian, WANG Hongyu. Analysis of the Current Status of Metabolic Syndrome among Middle-aged and Elderly People in Shijingshan District, Beijing, and Its Behavioral and Lifestyle Influencing Factors [J]. Chinese General Practice, 2026, 29(30): 4424-4430. |
| [14] | ZHANG Shuaishuai, CHEN Yue, QIU Jiaojiao, ZHU Ping, WANG Shuxia. Association between Remnant Cholesterol Inflammatory Index and Biological Age Acceleration in Middle-aged and Older Chinese Adults: a Nationwide Cohort Study [J]. Chinese General Practice, 2026, 29(30): 4397-4405. |
| [15] | LI Lan, LIU Lidi, ZHANG Peng, LI Dongze, YANG Ziyu, CHENG Yonglang, LIAO Xiaoyang, WAN Zhi. Lifestyle Intervention-based Weight Management: an Analysis of Key Highlights from the Partial Update of the 2025 NICE Guideline Overweight and Obesity Management (NG246) [J]. Chinese General Practice, 2026, 29(30): 4353-4359. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||